WO1999021611A1 - A system and method for cardioversion using scan stimulation - Google Patents
A system and method for cardioversion using scan stimulation Download PDFInfo
- Publication number
- WO1999021611A1 WO1999021611A1 PCT/US1998/022660 US9822660W WO9921611A1 WO 1999021611 A1 WO1999021611 A1 WO 1999021611A1 US 9822660 W US9822660 W US 9822660W WO 9921611 A1 WO9921611 A1 WO 9921611A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- heart
- pulse
- electrode
- pulses
- electrodes
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 45
- 230000000638 stimulation Effects 0.000 title description 32
- 238000013194 cardioversion Methods 0.000 title description 8
- 230000001225 therapeutic effect Effects 0.000 claims abstract description 50
- 230000033764 rhythmic process Effects 0.000 claims abstract description 44
- 230000002159 abnormal effect Effects 0.000 claims abstract description 41
- 238000004891 communication Methods 0.000 claims abstract description 33
- 230000001020 rhythmical effect Effects 0.000 claims abstract description 26
- 239000000835 fiber Substances 0.000 claims description 21
- 238000013528 artificial neural network Methods 0.000 claims description 16
- 230000004913 activation Effects 0.000 claims description 11
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims 1
- 235000011941 Tilia x europaea Nutrition 0.000 claims 1
- 239000004571 lime Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 description 11
- 238000001994 activation Methods 0.000 description 10
- 230000005684 electric field Effects 0.000 description 10
- 230000035939 shock Effects 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 208000001871 Tachycardia Diseases 0.000 description 7
- 206010003119 arrhythmia Diseases 0.000 description 6
- 208000003663 ventricular fibrillation Diseases 0.000 description 6
- 230000006793 arrhythmia Effects 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 230000001746 atrial effect Effects 0.000 description 4
- 210000002064 heart cell Anatomy 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 230000001788 irregular Effects 0.000 description 4
- 230000002861 ventricular Effects 0.000 description 4
- 206010003658 Atrial Fibrillation Diseases 0.000 description 3
- 206010049447 Tachyarrhythmia Diseases 0.000 description 3
- 206010061592 cardiac fibrillation Diseases 0.000 description 3
- 230000002600 fibrillogenic effect Effects 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 210000001174 endocardium Anatomy 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 210000003742 purkinje fiber Anatomy 0.000 description 2
- 210000005241 right ventricle Anatomy 0.000 description 2
- 230000006794 tachycardia Effects 0.000 description 2
- 206010047302 ventricular tachycardia Diseases 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000002763 arrhythmic effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000008713 feedback mechanism Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000002837 heart atrium Anatomy 0.000 description 1
- 230000002102 hyperpolarization Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000028161 membrane depolarization Effects 0.000 description 1
- 230000005055 memory storage Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 210000005245 right atrium Anatomy 0.000 description 1
- 210000000779 thoracic wall Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/3621—Heart stimulators for treating or preventing abnormally high heart rate
- A61N1/3622—Heart stimulators for treating or preventing abnormally high heart rate comprising two or more electrodes co-operating with different heart regions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3918—Heart defibrillators characterised by shock pathway, e.g. by electrode configuration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3956—Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Electrotherapy Devices (AREA)
Abstract
The present invention is a method, and system for applying therapeutic electrical pulses to the heart (12). A plurality of spaced apart electrodes (24), each electrode in electrical communication with a pulse generator (18), are operative to deliver at least one energy pulse to a patient's heart (12). Sensors (not shown) in electrical communication with a controller (16) are operative to detect an abnormal rhythm in the patient's heart (12), and transmit a signal to a controller (16) to indicate an abnormal rhythmic condition. The controller (16) is configured to receive the abnormal rhythmic signal from the sensor detector (not shown), cause the pulse generator (18) to emit a sequence of spatially, and temporally distinct pulses through the electrodes (24), each pulse passing through at least one of the electrodes (24).
Description
A SYSTEM AND METHOD FOR CARDIOVERSION TJSTNG SCAN STIMULATION
Field of the Invention
The present invention relates generally to a system and method for terminating a cardiac arrhythmia or fibrillation by applying therapeutic electrical pulses to the heart, and more particularly to such a method and system utilizing scan stimulation whereby temporally and spatially distinct electrical pulses are applied to a heart.
Background of the Invention A variety of physiological conditions exist where irregular electrical activity of a heart results in an abnormal heartbeat. To correct the abnormal heartbeat, a multiplicity of systems and methods have been developed whereby at least one therapeutic electrical shock or pulse is applied to the heart through one or two electrodes to disrupt the irregular electrical activity so that the heart may revert to its regular electrical activity, resulting in a normal heartbeat.
Such systems and methods utilize electrical field stimulation wherein a sufficiently large shock is applied to the heart through one or two electrodes to produce a desired extracellular potential gradient in large regions of the heart distant from the electrodes. In this manner, the irregular electrical activity throughout the heart is sufficiently disrupted to permit restoration of normal electrical activity and normal heartbeat.
Many prior art systems and methods first detect, through a variety of known devices, a rhythmic condition such as tachycardia (relatively rapid heart action), arrhythmia (an alteration in the rhythm of the heartbeat either in time or
force), tachyarrhythmia (arrhythmia characterized by a rapid, irregular heartbeat), and atrial or ventricular fibrillation (very rapid uncoordinated constrictions of the atria or ventricle, respectively, resulting in loss of the ability to pump blood, most particularly in the case of ventricular fibrillation). Next, an electrical shock is applied to the heart through one or two electrodes positioned on or within the heart. The electrical shock applied to the heart through the electrodes is large enough to produce an electric field in regions of the heart near and remote from the electrodes. Selected prior art systems include feedback mechanisms whereby the electrical condition of the heart is detected subsequent to the application of the first shock and, if a normal heart rhythm is not restored, an additional electrical shock is applied to the heart.
Measurements have recently been obtained utilizing optical mapping techniques with voltage-sensitive fluorescent dyes in hearts which indicate that the effects of an electrical stimulation pulse on the transmembrane potential of heart cells are greatest in the region within one millimeter of the stimulation electrode.
Because the strength of an electric field decreases with increasing distance from the electrodes, a pulse which produces an electric field sufficient for defibrillation in a region remote from an electrode will produce a much stronger electric field near the electrode. Injuries are produced in heart cells by such strong electrical stimulation when, during the electrical pulse, the tr-ansmembrane potential exceeds the threshold for cell membrane electroporation. As prior art cardioversion and defibrillation systems require the application of high voltage
pulses to the heart to produce an electric field in regions of the heart remote from the electrodes, such systems also have large energy requirements.
One method, disclosed in U.S. Patent No. 4,708,145 to Tacker, Jr. et al. attempts to avoid areas of high current density in the heart by using a sequential pulse, multiple pathway defibrillation method for controlling ventricular fibrillation and tachyarrhythmias. A catheter carrying a first and second electrode is located in the right ventricle and a third electrode is located either at the chest wall or at the abdominal cavity. The second and third electrodes are sequentially paired and pulsed with the first electrode to control ventricular fibrillation and other tachyarrhythmias. While the Tacker, Jr. et al device applies shocks to the heart through spaced apart electrodes, these shocks are intended to traverse the heart through particular pathways to establish a sufficient electric field in regions of the heart remote from the electrodes.
Since the effects of electrical shocks on transmembrane potentials are large near an electrode, a system to produce effects primarily in the cells near an electrode could require stimulation voltage or current that is less than the voltage or current needed to produce a desired electric field remote from an electrode. Such a system would require low current pulses which could decrease both the system energy requirements and cellular damage resulting from each electrical pulse. Low strength stimulation at a single site is already known to effect arrhythmias and even, as reported by Salama, halt ventricular tachycardia in isolated rapid hearts when applied to Purkinje fibers which occur on the endocardium.
Although the prior art provides a variety of cardioversion and defibrillation methods and systems, there remains a need for a method and system for cardioversion of a heart which utilizes low voltage pulses which minimizes damage to the heart with low power requirements. Summary of the Invention
The present invention is intended to produce effects on transmembrane potentials in the cells of the heart fiber proximate to each of a plurality of spaced apart electrodes rather than utilizing high energy pulses applied through one or two electrodes to produce a desired electric field in cells positioned away from an electrode. An abnormal rhythmic pattern of a heart is disrupted by the application of therapeutic electrical pulses through a plurality of spaced apart electrodes, resulting in stimulation of a sufficient number of cells. The present invention thus requires less stimulation voltage or current than conventional devices which produce an electric field remote from the electrodes, thereby decreasing both the energy requirements of the cardio verier or defibrillator and cellular damage to the heart.
The system of the present invention for applying therapeutic electrical pulses to a patient's heart includes a power source and a controller in electrical communication with the power source. A pulse generator, in electrical communication with the controller, is configured to generate a sequence of energy pulses. A plurality of spaced apart electrodes are provided, each electrode being in electrical communication with the pulse generator. Each electrode is configured to deliver .an energy pulse generated by the pulse generator to the patient's heart.
The controller is operative to cause the pulse means to direct, through the electrodes, a sequence of spatially and temporally distinct pulses to the heart.
Preferably, detecting means are provided which are in electrical communication with the controller. The detecting means are operative to detect an abnormal rhythm in a patient's heart and transmit a signal to the controller to indicate an abnormal rhythmic condition. In selected embodiments, the electrodes may be operative to detect electrical activation of heart fibers proximate to each such electrode. The controller is operative to receive the signal indicating an abnormal rhythmic condition and to cause the pulse means to direct, through the electrodes, a sequence of spatially and temporally distinct pulses to the patient' s heart, each pulse passing through at least one of the electrodes.
The method for applying therapeutic electrical pulses to the heart comprises the steps of providing a plurality of spaced apart electrodes, each electrode in electrical communication with heart fibers adjacent to such electrode. Preferably, an abnormal cardiac rhythmic condition such as fibrillation, tachycardia, tachyarrhythmias or the like is detected through detectors or sensors in contact with the heart. A sequence of spatially and temporally distinct pulses are directed to the heart, each pulse applied to the heart through at least one of the plurality of electrodes. In the preferred embodiment, a first pulse is directed to the heart to a first electrode at a time Tl and a second pulse is directed to the heart through a second electrode at time T2, time T2 being later in time than Tl.
Preferably, at least one of the electrodes is elongated and extends parallel to an elongated fiber of the heart which is positioned proximate to such electrode.
A wide variety of stimulation sequences may be utilized in the present invention, such as pairing a first and third electrode so that a first pulse is directed to the heart through a first electrode at time Tl and a third pulse is simultaneously directed to the heart through a third electrode at Tl. In such an embodiment, a second pulse may be directed to the heart through a second electrode at time T2 and a fourth pulse may be directed to the heart through a fourth electrode at a time T2. In any of the embodiments of the present invention, the pulses sequentially directed to the heart may have the same or opposite polarity.
The method may also include the step of storing the sequences of spatially and temporally distinct pulses which have been directed to the heart.
In the system of the present invention the controller may be operative to receive a first signal pattern from the detector or sensor, the first signal pattern being indicative of a first heart rhythm. The controller is further operative to determine if therapeutic electrical pulses are to be applied to the heart. Preferably, this step includes the step of sending the received signal pattern to an artificial neural network configured to recognize a signal pattern indicative of an abnormal heart rhythm. The controller is also preferably operative to receive from the artificial neural network a signal indicating if therapeutic electrical pulses are to be applied to the heart. In alternate embodiments, the step of determining if therapeutic electrical pulses are to be applied to the heart may include the steps of comparing the received signal pattern with at least one stored pattern indicative of acceptable heart rhythms. If the received signal pattern is comparable to at least one stored
pattern indicative of an acceptable heart rhythm, therapeutic electrical pulses are not to be directed to the heart. If the received signal pattern is not comparable to a stored pattern indicative of an acceptable heart rhythm, therapeutic electrical pulses are to be directed to the heart. If therapeutic electrical pulses are to be applied to the heart, the controller is operative thereafter to generate a first control signal and direct the first control signal to the pulse generator to cause the pulse generator to apply a first pattern of temporally and spatially separated pulses to the plurality of electrodes. The controller is further configured to receive a second signal pattern from the sensor means, the second signal pattern being indicative of a second heart rhythm. The controller is then configured to determine if therapeutic electrical pulses are to be applied to the heart using the steps discussed supra. If therapeutic electrical pulses are to be applied to the heart, the controller is configured to generate a second control signal and direct the second control signal to the pulse generator to cause the pulse generator to apply a second pattern of temporally and spatially separated pulses to the plurality of electrodes. If therapeutic electrical pulses are not to be applied to the heart, the second control signal is stored in association with the second signal pattern.
Other objects, advantages and applications of the present invention will be made clear by the following detailed description of a preferred embodiment of the present invention. The description makes reference to drawing in which:
Brief Description of the Drawings
FIGURE 1 is a view of an embodiment of the present mvention wherein the electrodes have been transvenously inserted into the heart;
FIGURE 2 is a view of an alternate embodiment of the present invention wherein the electrodes have been applied to the exterior of the heart beneath or upon the pericardium;
FIGURE 3 is a graphical representation of a sequence of electrode pulses over time;
FIGURE 4 is an alternate graphical representation of a sequence of electric pulses over time;
FIGURE 5 is yet another graphical representation of a sequence of electrode pulses over time;
FIGURE 6 is a view of the catheter of the present invention corresponding to the embodiment of FIGURE 1 during transvenous insertion; and FIGURE 7 is a view of the catheter with electrodes of the present invention corresponding to the embodiment of FIGURE 1 in their respective positions after transvenous insertion.
Detailed Description
As shown in Figure 1 , an implantable embodiment of the present invention includes a plurality of spaced apart electrodes 24 preferably positioned within the right ventricle 32 of the heart 12. Each electrode 24 is operative to deliver an energy pulse generated by a pulse generator 18 to the patient's heart. Each electrode may be in electrical communication with a discrete pulse generator 18,
or a single pulse generator 18 may be in electrical communication with all or a subset of the electrodes 24, such pulse generator being operative to selectively direct a pulse through each electrode.
In the preferred embodiment, at least four and preferably six electrodes are utilized, although more or less may be successfully utilized in the present invention. The electrodes may also be arranged to contact the heart in any of a variety of ways, including a preformed "sock" of spaced electrodes which envelop the heart. The electrodes may be positioned anywhere in or on the heart.
In Figures 6 and 7, a preferred embodiment of the electrodes 24 is shown therein, the electrodes emanating from a single point at the lower end of a catheter
26. For transvenous insertion of the electrodes of the present invention, a sheath 28 may be placed over the electrodes 24 during insertion into the heart 12. Once the electrodes 24 and catheter 26 have been inserted into the proper cavity of the heart, the sheath 28 may be removed from the heart 12, thereby allowing the electrodes 24 to fan out and lie against the heart fibers. The electrode arrangement depicted in Figures 6 and 7 may be removed from the heart by sliding the sheath 28 over the catheter 26 and, by withdrawing the catheter 26 out of the heart cavity, flexible electrodes 24 are gradually drawn into sheath 28.
Preferably, each electrode is elongated and of the type described in U.S. Patent Application Serial No. 08/717,416, entitled Line Electrode Oriented
Relative to Fiber Direction, which is incorporated herein by reference. Each electrode 24 is preferably configured to lie in a direction parallel to an adjacent heart fiber. The utilization of an elongated electrode which is configured to lie
parallel to an elongated fiber of the heart provides particular advantages to any cardioversion system, as low power energy pulses applied to the heart through such particularly positioned electrodes reduces the spatial variation of transmembrane voltages in cells proximate to the electrodes, and minimizes the likelihood of inducing arrhythmic activity such as that described by Saypol for point stimulation. Such particularly positioned electrodes may lessen damage to heart cells proximate to such electrodes.
In the preferred embodiment of Figure 1, a controller 16, in electrical communication with a power source 14, is operative to cause the pulse generator to direct a sequence of spatially and temporally distinct pulses to the heart 12 through the spaced apart electrodes 24, each pulse passing through at least one of the electrodes 24. The controller 16 may be operative to cause each of a plurality of pulse generators 18 to direct an energy pulse through the electrode 24 in electrical communication with each pulse generator so that a sequence of temporally distinct pulses is directed through the spaced apart electrodes.
Alternately, the controller may be configured to cause the pulse generator to direct a series of pulses through the plurality of electrodes in electrical communication with the pulse generator 18. Such a series of pulses or "scan" is intended to disrupt the abnormal heart rhythm and reestablish normal heart rhythm in the patient.
Scan stimulation of a heart may occur in a random pattern wherein the spaced apart electrodes 24 are randomly pulsed, or a predetermined pattern wherein the electrodes are pulsed in a clockwise or counter-clockwise sequence
.around the heart. Alternatively, a scan pattern could first stimulate an endocardial electrode positioned near the heart apex and scan on the endocardium of ventricular walls towards the base of the heart, thus mimicking the propagation of electrical impulses from the Purkinje fibers that excite the ventricular walls in normal heart rhythm. Stimulation patterns could be particularly configured to increase the effectiveness of the ventricular or atrial defibrillation or cardioversion. The sequence of scan stimulation may vary considerably and is preferably customized to the rhythmic abnormality.
Figures 3, 4 and 5 depict stimulation sequences which may be applied to the heart. Unipolar or bipolar stimulation may be applied through the electrodes
24. The electrodes may be "paired" so that, at a given time T, two of the spaced apart electrodes direct energy pulses simultaneously to the heart. Such pulses may be of the same or opposite polarity. The controller 16 and pulse generators 18 may be configured so that the scan can be performed with different polarities and different electrodes at different times so that hyperpolarization and depolarization occur in cells near each electrode. Since each electrode may deliver a stimulation occurring at a different time during a scan, the effects of such pulses on cells at numerous locations in the heart could produce ventricular or atrial defibrillation or cardioversion. Figure 2 depicts an embodiment of the present invention wherein electrodes 24 are positioned on the epicardium of the heart, such electrodes being preferably aligned with the elongated fibers 20 of the heart 12. An electrical pulse generator 18 is in electrical communication with a controller 16 and the electrodes
24. The controller 16 is in electrical communication with a detector 30 which is configured to sense myocardial activations, thus detecting an abnormal rhythmic condition in the patient's heart such as atrial or ventricular fibrillation, tachyarrhythmia, or arrhythmia. Myocardial activations could be sensed at the electrodes 24 and transmitted to controller 16, the electrodes thus functioning as sensors or detectors. Alternately, separate sensors may be utilized.
Upon detection of an abnormal rhythmic condition in the heart 12, the detector 30 transmits a signal which is indicative of the abnormal rhythmic condition to the controller 16. The detector 30 may be configured to send a particular signal which is indicative of ventricular fibrillation, atrial fibrillations, tachyarrhythmia or the like to the controller 16. The controller 16 is operative to receive such signal and cause the pulse generator 18 to direct an appropriate sequence of temporally and spatially distinct pulses through the spaced apart electrodes. In a preferred embodiment, scan sequences are configured to terminate the particular rhythmic abnormality detected. Such sensing and control of stimulation could be performed with digital and/or analog processing circuitry which could operate in real time with low energy in an implantable device.
Additionally, the controller may include or be in electrical communication with a memory 32. Upon detection of an abnormal rhythmic condition, the controller 16 may be configured to retrieve from a predetermined location in the memory 32 the appropriate scan stimulation sequence to terminate such an abnormal rhythmic condition. The controller may alter the scan sequence at any time to accommodate rhythmic or other changes detected in the heart. Memory
32 may also store previously detected abnormal rhythmic conditions as well as the sequence of temporally and spatially distinct pulses which terminated such abnormal rhythmic condition. Additionally, the controller may be operative to perform data base functions such as sorting, selecting and the like on the information stored in memory 32 to determine the most effective and safest way to restore a normal rhythm to the heart. The controller may use the information stored in memory in combination with a program or the like to create a new sequence of pulses to be applied to the heart as well as to determine the most effective scan sequence for the patient, store that sequence and change its program to utilize that successful sequence in future defibrillation episodes.
At implantation in patients, the stimulation electrodes 24 could also be used as recording electrodes to map the arrhythmia or other condition by connecting the signals to an external recording system or memory 32. Also, internal memory storage and readout of stored recordings could be performed by physicians after implantation.
If an electrode applies stimulation too soon after the intrinsic activation of the heart cells proximate to the electrode, the site is absolutely refractory at this point in time and may not be effected by an additional stimulation pulse. Such unnecessary application of stimulation would waste energy and potentially damage the cells. To overcome such problems, the controller 16 may direct a stimulation pulse to an electrode a preselected time after the last activation was sensed by that electrode, thus, preventing waste of stimulation energy and unnecessary risk of damage to the heart.
The scan may be programmed to follow an approximate spatial path in a tissue which is the same path as the last activation detected by the detector 30, the retrograde direction of the same path, or the direction of the path perpendicular or otherwise angularly positioned to the path of the last activation. The scan may also be sequenced to halt the fibrillation activation fronts without producing new activation fronts. Alternately, scan pacing could be controlled from sensing in the right atrium. This would allow timing of the stimulation to produce summation of stimulation together with the intrinsic activation of the heart pacemaker and conduction system, thus reducing the stimulation energy required and helping to quickly restore a normal rhythmic pattern.
In an alternate embodiment, the temporally distinct pulses may be spaced apart by no less than two milliseconds, although smaller and larger time increments may be utilized. Additionally, a first pulse may be emitted by an electrode, a second pulse being emitted by a different electrode after the beginning of the first pulse .and before or concurrent with the ending of the first pulse.
Preferably, the beginning of a pulse occurs less than 100 microseconds after the ending of the immediately preceding pulse.
The controller of the present invention is operative to receive a first signal pattern from the sensor or detector. This first signal pattern is indicative of a first heart rhythm, whether such rhythm be normal or abnormal. Next, the controller determines if the therapeutic electrical pulses are to applied to the heart. In the preferred embodiment, the controller sends the received signal pattern to an artificial neural network with back propagation. Such an artificial neural network
is operative to recognize a signal pattern which is indicative of an abnormal heart rhythm. It is known in the art that such parallel distributed processing devices process vast amounts of information efficiently. Such artificial neural networks can "learn" to associate a particular input with a given output. In application in the present invention, a signal indicative of a heart rhythm can be input to an artificial neural network which has been "taught" to recognize a signal indicative of an abnormal heart rhythm.
Next, the controller receives, from the artificial neural network, a signal indicating if the received signal pattern is recognized as an abnormal heart rhythm. If the received signal pattern is recognized as an abnormal heart rhythm by the artificial neural network, the artificial neural network sends a signal to the controller indicating that therapeutic electrical pulses are to be applied to the heart. If the artificial neural network does not recognize the received signal pattern as a signal pattern indicative of an abnormal rhythm, the artificial neural network sends a signal to the controller indicating that therapeutic electrical pulses are not to be applied to the heart. The controller is operative to receive these signals from the artificial neural network. If the controller has received a signal from the artificial neural network that the heart rhythm is indicative of an abnormal heart rhythm, the controller is operative to generate a first control signal associated with a first pattern of temporally and spatially separated pulses, and direct the first control signal to the pulse generator. The first control signal is operative to cause the pulse generator to apply the first pattern of temporally and spatially separated pulses to the plurality of electrodes to restore a normal heart rhythm.
If therapeutic pulses are applied to the heart, the controller then receives a second signal pattern from the sensors or detectors, the second signal pattern being indicative of a second heart rhythm. The controller again determines if therapeutic electrical pulses are to be applied to the heart by communicating with an artificial neural network. Alternately, the controller may determine if therapeutic electrical pulses are to be applied to the heart by comparing the received signal pattern with at least one stored pattern indicative of acceptable heart rhythms. If the received signal pattern is comparable to at least one stored pattern indicative of an acceptable heart rhythm, therapeutic electrical pulses are not applied to the heart. Alternately, if the received signal pattern is not comparable to a stored pattern indicative of an acceptable heart rhythm, therapeutic electrical pulses are applied to the heart.
If therapeutic electrical pulses are to be directed to the heart after receipt of the second signal pattern, the controller generates a second control signal associated with a second pattern of temporally and spatially separated pulses and directs the second control signal to the pulse generator to cause the pulse generator to apply the second pattern of temporally and spatially separated pulses to the plurality of electrodes. If therapeutic electrical pulses are not to be applied to the heart after receipt of the second signal pattern from the sensors, the controller is configured to store the second control signal in association with the second received signal pattern. Thus, the system of the present invention stores which sequence was effective in terminating a particular heart rhythm.
The electrodes may be activated individually, in pairs or in groups. If four electrodes are activated in pairs, the first and third electrodes may be paired while the second and fourth electrodes are paired. In an embodiment utilizing six electrodes, the first and fourth electrodes may be paired, the second and fifth electrodes may be paired and the third and sixth electrodes may be paired. Thus, a pair of pulses may be transmitted to the heart through the first and fourth electrodes at a time Tl, such energy pulses having the same or opposite polarities. At a time T2, subsequent to the first pair of pulses, another pair of pulses are emitted through a second and fifth electrodes. Likewise, a third pair of pulses are emitted through the third and sixth electrodes at a time T3 subsequent to the previous two pairs of pulses.
An almost limitless number of scan sequences may be designed to be applied through the spaced apart elecfrodes. Figures 3-5 graphically depict a variety of scan stimulation patterns which may be applied through six electrodes. As shown in Figure 3, a scan sequence is depicted wherein a pulse is emitted through each electrode sequentially. At time Tl, a first pulse is emitted through electrode 1, and a second pulse is emitted through electrode 2 at time T2. Likewise, a third pulse is emitted through electrode 3 at time T3, a fourth pulse is emitted through electrode 4 at T4, a fifth pulse is emitted through electrode 5 at T5, and a sixth pulse is emitted through electrode 6 at T6. As shown in Figure 3, each pulse has the same polarity. Figure 4 depicts an alternate pattern wherein electrodes 1 and 4 are paired, electrodes 2 and 5 are paired, and electrodes 3 and 6 are paired. At time Tl, electrodes 1 and 4 emit a positive pulse. At time T2,
electrodes 2 and 5 emit a positive pulse and, at time T3, electrodes 3 and 6 emit positive pulses. At time T4, electrodes 1 and 4 emit a negative pulse to the heart, at time T5 electrodes 2 and 5 emit a negative pulse to the heart and, at time T6, electrodes 3 and 6 emit negative pulses to the heart. In a scan sequence depicted in Figure 5, electrode 1 emits, at Tl, a positive pulse while electrode 4 simultaneously emits a negative pulse. At time T2, electrode 2 emits a positive pulse and electrode 5 emits a negative pulse. At time T3, electrode 3 emits a positive pulse while electrode 6 emits a simultaneous pulse which is negative. At time T4, electrode 1 emits a negative pulse and electrode 4 emits a positive pulse. At time T5, electrode 2 emits a negative pulse and electrode 5 emits a positive pulse. At time T6, electrode 3 emits a negative pulse and electrode 6 emits a positive pulse. A seemingly infinite variety of scan stimulation sequences may be created depending on the number of electrodes selected and the polarity and sequence of pulsing of such electrodes. In a preferred embodiment a first pulse beginning at time Tl and ending at time T3 is emitted. A second pulse, beginning at time T2, is emitted after Tl but before T3. Alternately, the second pulse may begin at time T3, the beginning of the second pulse occurring simultaneously with the ending of the first pulse.
Having described the various embodiments of the present invention with reference to the accompanying figures, it will be appreciated that various changes and modifications can be made without departing from the scope or spirit of the invention.
I claim:
Claims
Claims 1. A method for applying therapeutic electrical pulses to the heart comprising the steps of: providing a plurality of spaced apart elecfrodes, each electrode in electrical communication with a heart fiber adjacent to the electrode; and directing a sequence of spatially and temporally distinct pulses to the heart, each pulse applied to the heart through at least one of the plurality of electrodes.
2. The method of claim 1 wherein the step of directing a sequence of spatially and temporally distinct pulses to the heart further comprises the steps of: directing a first pulse to the heart through a first electrode at a time Tl; and directing a second pulse to the heart through a second electrode at a time T2, T2 being later in time than Tl .
3. The method of claim 2 wherein the step of directing a second pulse to the heart includes the step of directing a second pulse to the heart through a second electrode at a time T2, T2 occurring at least two milliseconds after Tl .
4. The method of claim 1 wherein the step of providing a plurality of electrodes includes the step of providing a plurality of elongated electrodes, at
least one electrode extending substantially parallel to an elongated fiber of the heart proximate to such electrode.
5. The method of claim 1 further including the step of detecting an abnormal heart rhythm.
6. The method of claim 1 wherein the step of providing a plurality of electrodes includes the step of providing at least four electrodes.
7. A method for applying therapeutic electrical pulses to the heart comprising the steps of : providing a plurality of electrodes, each electrode in electrical communication with a heart fiber adjacent to such electrode; providing a pulse generator which generates energy pulses; detecting an abnormal heart rhythm; directing a first pulse to the heart through a first electrode at a time Tl; and directing a second pulse to the heart through a second electrode at a time T2, T2 being later in time than T 1.
8. The method of claim 7 further comprising the steps of: directing a third pulse to the heart through a third electrode at time T3, T3 being later in time than T2;
directing a fourth pulse to the heart through a fourth electrode at time T4, T4 being later in time than T3; directing a fifth pulse to the heart through a fifth electrode at time T5, T5 being later in time than T4; and directing a sixth pulse to the heart through a sixth electrode at time T6, T6 being later in time than T5.
9. The method of claim 7 further including the steps of: directing a third pulse to the heart through a third electrode at time Tl; and directing a fourth pulse to the heart through a fourth electrode at time T2.
10. The method of claim 9 wherein the first and third pulses have the same polarity.
11. The method of claim 9 wherein the first and third pulses have opposite polarity.
12. The method of claim 7 further including the steps of: directing a third pulse to the heart through a third electrode at time T3, T3 being later in time than T2;
directing a fourth pulse to the heart through a fourth electrode at time Tl; directing a fifth pulse to the heart through a fifth electrode at time T2; and directing a sixth pulse to the heart through a sixth electrode at time T3.
13. The method of claim 7 wherein the step of providing a plurality of electrodes includes the step of providing a plurality of elongated electrodes, at least one electrode extending substantially parallel to an elongated fiber of the heart proximate to such electrode.
14. The method of claim 7 further including the step of storing the sequence of spatially and temporally applied pulses directed to the heart.
15. A system for applying therapeutic electrical pulses to the heart comprising: a power source; a controller in electrical communication with the power source; pulse means in electrical communication with the controller and power source, the pulse means configured to generate a sequence of energy pulses ;
a plurality of spaced apart electrodes, each electrode in electrical communication with the pulse means, each electrode configured to deliver at least one of the energy pulses generated by the pulse means to a patient's heart; detecting means in electrical communication with the controller, the detecting means operative to detect an abnormal rhythmic condition in the patient's heart and transmit a signal to the controller to indicate an abnormal rhythmic condition, the controller being operative to receive the signal indicative of an abnormal rhythmic condition and to cause the pulse means to direct a sequence of spatially and temporally distinct pulses to the patient's heart through the electrodes, each pulse passing through at least one of the electrodes.
16. The system of claim 15 comprising at least four electrodes.
17. The system of claim 15 wherein each of the plurality of spatially and temporally distinct pulses has a beginning and an ending, the beginning of each pulse being spaced apart from the beginning of the immediately preceding pulse.
18. The system of claim 17 wherein the beginning of each pulse is spaced apart from the ending of the immediately preceding pulse by no more that 100 microseconds.
19. The system of claim 15 wherein each electrode is an elongated electrode configured to be positioned substantially parallel to a fiber of the patient's heart.
20. The system of claim 15 further including memory means in electrical communication with the controller.
21. The system of claim 20 wherein the memory means is configured to store at least two different sequences of spatially and temporally distinct pulses.
22. The system of claim 21 wherein each stored sequence of spatially and temporally distinct pulses is associated with an indicator, also stored in memory, which associates the sequence of pulses with at least one type of abnormal rhythmic condition detectable by the detecting means.
23. The system of claim 15 wherein the controller is further operative to direct a first sequence of spatially and temporally distinct pulses to the heart and, if the detecting means transmits a signal indicative of an abnormal rhythmic condition in the patient's heart to the controller after application of the first sequence of pulses, the controller being further operative to direct a second sequence of pulses to the heart.
24. The system of claim 23 wherein the second sequence of pulses differs from the first sequence of pulses.
25. The system of claim 15 wherein the electrodes are operative to detect electrical activation of heart fibers proximate to each such electrode.
26. A system for applying therapeutic electrical pulses to a heart comprising: L a plurality of spaced apart electrodes configured to be disposed in contact with a heart; II. sensor means configured to be disposed in contact with the heart; III. a pulse generator in electrical communication with the plurality of electrodes, the pulse generator being operative to apply a pattern of temporally and spatially separated pulses to the heart through the plurality of electrodes; IV. a controller in electrical communication with the plurality of electrodes, the sensor means and the pulse generator, the controller being operative to: a. receive a first signal pattern from the sensor means, the first signal pattern being indicative of a first heart rhythm; b. determine if therapeutic electrical pulses are to be applied to the heart;
if therapeutic electrical pulses are to be applied to the heart, c. generate a first control signal; d. direct the first control signal to the pulse generator to cause the pulse generator to apply a first pattern of temporally and spatially separated pulses to the plurality of electrodes; e. receive a second signal pattern from the sensor means, the second signal pattern being indicative of a second heart rhythm; f. determine if therapeutic electrical pulses are to be applied to the heart; if therapeutic electrical pulses are to be applied to the heart, g. generate a second control signal; h. Direct the second control signal to the pulse generator to cause the pulse generator to apply a second pattern of temporally and spatially separated pulses to the plurality of electrodes; and if therapeutic electrical pulses are not to be applied to the heart, i. store the second control signal in association with the second signal pattern.
27. The system claimed in claim 26 wherein the steps of determining peutic electrical pulses are to be applied to the heart includes the steps of:
sending the received signal pattern to an artificial neural network configured to recognize a signal pattern indicative of an abnormal heart rhythm; and receiving from the artificial neural network a signal indicating if therapeutic electrical pulses are to be directed to the heart.
28. The system claimed in claim 26 wherein the steps of determining if therapeutic electrical pulses are to be directed to the heart include the steps of: comparing the received signal pattern with at least one stored pattern indicative of acceptable heart rhythms; if the received signal pattern is comparable to at least one stored pattern indicative of an acceptable heart rhythm, therapeutic electrical pulses are not to be directed to the heart; and if the received signal pattern is not comparable to at least one stored pattern indicative of an acceptable heart rhythm, therapeutic electrical pulses are to be directed to the heart.
29. A method for applying therapeutic electrical pulses to the heart comprising the steps of: providing a plurality of spaced apart electrodes configured to be disposed in contact with a heart; providing sensor means configured to be disposed in contact with
the heart;
providing a pulse generator in electrical communication with the plurality of electrodes and sensor means , the pulse generator being operative to apply a pattern of temporally and spatially separated pulses to the heart through the plurality of electrodes; receiving a first signal pattern from the sensor means, the first signal pattern being indicative of a first heart rhythm; determining if therapeutic electrical pulses are to be applied to the heart; storing the first control signal in association with the first signal pattern; if therapeutic electrical pulses are to be applied to the heart, generating a first control signal; directing the first control signal to the pulse generator to cause the pulse generator to apply a first pattem of temporally and spatially separated pulses through the plurality of electrodes; receiving a second signal pattem from the sensor means, the second signal pattem being indicative of a second heart rhythm; determining if therapeutic electrical pulses are to be applied to the heart; and if therapeutic electrical pulses are to be applied to the heart, generating a second control signal directing the second control signal to the pulse generator to cause the pulse generator to direct a second pattem of temporally and spatially separated pattem of pulses to the plurality of electrodes; and
if therapeutic electrical pulses are not to be applied to the heart, storing the second control signal in association with the second signal pattem.
AMENDED CLAIMS
[received by the International Bureau on 12 March 1999 (12.03.99); original claims 1, 2, 7, 10. 11 and 15 amended; new claim 30 added; remaining claims unchanged (7 pages)]
1 A method for applying therapeutic electrical pulses to the heart comprising the steps of:
3 providing a plurality of spaced-apart electrodes, each electrode in electrical communication with a heart fiber .adjacent to the electrode;
5 directing a sequence of spatially and temporally distinct pulses to
6 the heart wherein the sequence comprises a first pulse to the heart through a first
7 electrode at a time Tl, a second pulse to the heart through a second electrode at S a time T2, occurring at least two milliseconds after T 1.
1 2. A method for applying therapeutic electrical pulses to the heart
2 comprising the steps of:
3 providing a plurality of electrodes, each electrode in electrical
4 communication with a heart fiber adjacent to such electrode;
5 providing a pulse generator which generates energy pulses;
6 detecting an abnormal heart rhythm;
7 directing a first pulse to the heart through a first electrode at a time
8 Tl;
9 directing a second pulse to the heart through a second electrode at 0 a time T2, T2 being later in time than T 1 ; ] directing a third pulse to the heart through a third electrode at a 2 time T3, T3 being lat<ϊr in time than T2.
3. The method of claim 2 wherein the step of directing a second pulse to, the heart includes the step of directing a second pulse to the heart through a second electrode at a time T2, T2 occurring at least two milliseconds after Tl .
4. The method of claim 1 wherein the st-sp of providing a plur ity of electrodes includes the step of providing a plurality of elongated electrodes, at least one electrode extending substantially parallel to an elongated fiber of the heart proximate to such electrode.
5. The method of claim 1 further including the step of detecting an abnormal heart rhythm.
6. The method of claim 1 wherein the step of providing a plurality of electrodes includes the step of providing at least four electrodes.
7. A method for applying therapeutic electrical pulses to the heart comprising the steps o : providing a plurality of electrodes, each electrode in electrical communication with a heart fiber adjacent to such electrode; providing a pulse generator which generates energy pulses; detecting an abnormal heart rhythm; directing a first pulse to the heart through a first electrode at a time Tl ; and
AMFNDED SHEET (ARTICLE 19)
directing a second pulse to the heart through a second electrode at a time T2, T2 occurring at least two milliseconds after Tl .
8. The method of claim 7 further comprising the steps of: directing a third pulse to the heart through a third electrode at time T3, T3 being later in time than T2; directing a fourth pulse to the heart through a fourth electrode at time T4, T4 being later in time than T3; directing a fifth pulse to the heart through a fifth electrode at lime T5, T5 being later in time than T4; and directing a sixth pulse to the heart through a sixth electrode at time T6, T6 being later in time than T5.
9. The method of claim 7 further including the steps of: directing a third pulse to the heart through a third electrode at time Tl; and directing a fourth pulse to the heart through a fourth electrode at time T2.
10. The method of claim 9 wherein directing said first and third pulses includes directing pulses having the same polarity.
11. The method of claim 9 wherein directing said first and third pulses includes directing pulses having opposite polarity.
12. The m-sthod of claim 7 further including the steps of: directing a third pulse to the heart through a third electrode at time T3, T3 being later in time than T2; directing a fourth pulse to the heart through a fourth electrode at time Tl; directing a fifth pulse to the heart through a fifth electrode at time T2; and directing a sixth pulse to the heart through a sixth electrode at time T3.
13. The method of claim 7 wherein the step of providing a plurality of electrodes includes the step of providing a plurality of elongated electrodes, at least one electrode extending substantially parallel to an elongated fiber of the heart proximate to such electrode.
14. The method of claim 7 further including the step of storing the sequence of spatially and temporally applied pulses directed to the heart
15. A system for applying therapeutic electrical pulses to the heart comprising:
a power source; a controller in electrical communication with the power source; pulse means in electrical communication with the controller and power source, the pulse means configured to generate a sequence of energy pulses; a plurality of spaced apart elongated electrodes, each electrode m electrical communication with the pulse means, each electrode configured to deliver at least one of the energy pulses generated by the pulse means to a patient's heart; and detecting means in electrical communication with the controller, the detecting means operative to detect an abnormal rhythmic condition in the patient's heart and transmit a signal to the controller to indicate an abnormal rhythmic condition, the controller being operative to receive the signal indicative of an abnormal rhythmic condition and to cause the pulse means to direct a sequence of spatially and temporally distinct pulses to the patient' s heart through the electrodes, each pulse passing through at least one of the electrodes.
16. The system of claim 15 comprising at least four electrodes.
17. The system of claim 15 wherein each of the plurality of spatially and temporally distinct pulses has a beginning and an ending, the beginning of each pulse being spaced apart from the beginning of the immediately preceding pulse.
18. The system of claim 17 wherein the beginning of each pulse is spaced apart from the ending of the immediately preceding pulse by no more that 100 microseconds.
if therapeutic electrical pulses are not to be applied to the heart, storing the second control signal in association with the second signal pattem.
30. A method for applying therapeutic electrical pulses to the heart comprising the steps of: providing a plurality of electrodes, each electrode in electrical communication with a heart fiber adjacent to such electrodes; providing a pulse generator which generates energy pulses; detecting an abnormal heart rhythm; directing a first pulse to the heart through a first electrode at a time Tl; directing a second pulse to the heart through a second electrode at a time T2, T2 being later in time than T 1 ; directing a third pulse to the heart through a third electrode at a time Tl; and directing a fourth pulse to the heart through a fourth electrode at a time T2.
STATEMENT TINDER ARTTCT 1 9(1 )
Claims 1, 2, 7, 10, 11 and 15 have been amended to place the application in conformance with the corresponding United States patent application which contains allowed subject matter and to better define over the cited prior art.
Claim 1 has been amended to positively r-scite a time lapse of at least two milliseconds between Tl and T2.
Claim 2 has been amended to positively recite the provision of a plurality of electrodes and a pulse generator, as well as directing the generation of third through sixth pulses sequentially alter Tl and T2.
Claim 7 has been amended to positively recite that a second pulse occurs at a time T2 at least two milliseconds after Tl .
Claims 10 and 1 1 have been amended to reflect the antecedent basis of claim 9.
Claim 15 has been amended to positively recite that the plurality of spaced apart electrodes are elongated electrodes.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/960,448 | 1997-10-29 | ||
| US08/960,448 US5995871A (en) | 1997-10-29 | 1997-10-29 | System and method for cardioversion using scan stimulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1999021611A1 true WO1999021611A1 (en) | 1999-05-06 |
Family
ID=25503167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1998/022660 WO1999021611A1 (en) | 1997-10-29 | 1998-10-26 | A system and method for cardioversion using scan stimulation |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | US5995871A (en) |
| WO (1) | WO1999021611A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001021254A1 (en) * | 1999-09-23 | 2001-03-29 | Ben-Gurion University Of The Negev Research & Development Authority | Method and device for the cancellation of unwanted excitation waves in the heart |
| EP1696999A2 (en) * | 2003-07-21 | 2006-09-06 | Ai-Semi Ltd. | Adaptive resynchronization therapy system |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6537771B1 (en) * | 1999-10-08 | 2003-03-25 | Caliper Technologies Corp. | Use of nernstein voltage sensitive dyes in measuring transmembrane voltage |
| US6640135B1 (en) * | 2000-04-06 | 2003-10-28 | Cardiac Pacemakers, Inc. | Apparatus and method for spatially and temporally distributing cardiac electrical stimulation |
| US6628988B2 (en) | 2001-04-27 | 2003-09-30 | Cardiac Pacemakers, Inc. | Apparatus and method for reversal of myocardial remodeling with electrical stimulation |
| US7346394B2 (en) * | 2001-04-27 | 2008-03-18 | Cardiac Pacemakers, Inc. | Cardiac stimulation at high ventricular wall stress areas |
| US6829506B2 (en) * | 2001-07-25 | 2004-12-07 | Cardiac Pacemakers, Inc. | Linear stimulation of the heart for improved hemodynamic benefit |
| US6907286B1 (en) | 2001-10-19 | 2005-06-14 | Pacesetter, Inc. | Anti-tachycardia pacing methods and devices |
| US6754531B1 (en) | 2001-10-19 | 2004-06-22 | Pacesetter, Inc. | Anti-tachycardia pacing methods and devices |
| US6795731B1 (en) | 2001-10-19 | 2004-09-21 | Pacesetter, Inc. | Anti-tachycardia pacing methods and devices |
| US6766196B1 (en) | 2001-10-19 | 2004-07-20 | Pacesetter, Inc. | Anti-tachycardia pacing methods and devices |
| US6731982B1 (en) | 2001-10-19 | 2004-05-04 | Pacesetter, Inc. | Anti-tachycardia pacing methods and devices |
| US6973349B2 (en) | 2001-12-05 | 2005-12-06 | Cardiac Pacemakers, Inc. | Method and apparatus for minimizing post-infarct ventricular remodeling |
| US6915160B2 (en) * | 2002-02-08 | 2005-07-05 | Cardiac Pacemakers, Inc. | Dynamically optimized multisite cardiac resynchronization device |
| US7021645B1 (en) * | 2002-03-05 | 2006-04-04 | Pivit Hitch, Inc. | Pivoting hitch system for trailer |
| US6957105B2 (en) | 2002-03-26 | 2005-10-18 | Cardiac Pacemakers, Inc. | Method and apparatus for detecting oscillations in cardiac rhythm with electrogram signals |
| US6965797B2 (en) * | 2002-09-13 | 2005-11-15 | Cardiac Pacemakers, Inc. | Method and apparatus for assessing and treating myocardial wall stress |
| US20040088014A1 (en) * | 2002-10-31 | 2004-05-06 | Burnes John E. | Multi-site anti-tachycardia pacing with programmable delay period |
| US7065405B2 (en) * | 2002-11-15 | 2006-06-20 | Cardiac Pacemakers, Inc. | Stress reduction pacing mode for arrhythmia prevention |
| US9082156B2 (en) * | 2005-08-17 | 2015-07-14 | Jeffrey A. Matos | Emergency management system |
| US20070197859A1 (en) * | 2003-11-07 | 2007-08-23 | Paracor Medical, Inc. | Cardiac harness having diagnostic sensors and method of use |
| US8175702B2 (en) | 2004-11-04 | 2012-05-08 | The Washington University | Method for low-voltage termination of cardiac arrhythmias by effectively unpinning anatomical reentries |
| US8423139B2 (en) | 2004-12-20 | 2013-04-16 | Cardiac Pacemakers, Inc. | Methods, devices and systems for cardiac rhythm management using an electrode arrangement |
| US8050756B2 (en) | 2004-12-20 | 2011-11-01 | Cardiac Pacemakers, Inc. | Circuit-based devices and methods for pulse control of endocardial pacing in cardiac rhythm management |
| US8014861B2 (en) | 2004-12-20 | 2011-09-06 | Cardiac Pacemakers, Inc. | Systems, devices and methods relating to endocardial pacing for resynchronization |
| US8010191B2 (en) | 2004-12-20 | 2011-08-30 | Cardiac Pacemakers, Inc. | Systems, devices and methods for monitoring efficiency of pacing |
| US8010192B2 (en) | 2004-12-20 | 2011-08-30 | Cardiac Pacemakers, Inc. | Endocardial pacing relating to conduction abnormalities |
| US8326423B2 (en) | 2004-12-20 | 2012-12-04 | Cardiac Pacemakers, Inc. | Devices and methods for steering electrical stimulation in cardiac rhythm management |
| US8005544B2 (en) | 2004-12-20 | 2011-08-23 | Cardiac Pacemakers, Inc. | Endocardial pacing devices and methods useful for resynchronization and defibrillation |
| US8290586B2 (en) * | 2004-12-20 | 2012-10-16 | Cardiac Pacemakers, Inc. | Methods, devices and systems for single-chamber pacing using a dual-chamber pacing device |
| AR047851A1 (en) | 2004-12-20 | 2006-03-01 | Giniger Alberto German | A NEW MARCAPASOS THAT RESTORES OR PRESERVES THE PHYSIOLOGICAL ELECTRIC DRIVING OF THE HEART AND A METHOD OF APPLICATION |
| US7366567B2 (en) | 2005-03-23 | 2008-04-29 | Cardiac Pacemakers, Inc. | Method for treating myocardial infarction |
| US8108034B2 (en) | 2005-11-28 | 2012-01-31 | Cardiac Pacemakers, Inc. | Systems and methods for valvular regurgitation detection |
| CA2673971C (en) | 2006-11-13 | 2016-07-19 | Washington University Of St. Louis | Cardiac pacing using the inferior nodal extension |
| AU2008335087B2 (en) * | 2007-12-11 | 2013-10-24 | Washington University Of St. Louis | Method and device for low-energy termination of atrial tachyarrhythmias |
| US8560066B2 (en) | 2007-12-11 | 2013-10-15 | Washington University | Method and device for three-stage atrial cardioversion therapy |
| US8874208B2 (en) | 2007-12-11 | 2014-10-28 | The Washington University | Methods and devices for three-stage ventricular therapy |
| US8483841B2 (en) * | 2008-12-12 | 2013-07-09 | Cameron Health, Inc. | Electrode spacing in a subcutaneous implantable cardiac stimulus device |
| US8688234B2 (en) | 2008-12-19 | 2014-04-01 | Cardiac Pacemakers, Inc. | Devices, methods, and systems including cardiac pacing |
| US8565880B2 (en) | 2010-04-27 | 2013-10-22 | Cardiac Pacemakers, Inc. | His-bundle capture verification and monitoring |
| US8473051B1 (en) | 2010-12-29 | 2013-06-25 | Cardialen, Inc. | Low-energy atrial cardioversion therapy with controllable pulse-shaped waveforms |
| US10905884B2 (en) | 2012-07-20 | 2021-02-02 | Cardialen, Inc. | Multi-stage atrial cardioversion therapy leads |
| US8868178B2 (en) | 2012-12-11 | 2014-10-21 | Galvani, Ltd. | Arrhythmia electrotherapy device and method with provisions for mitigating patient discomfort |
| EP4192574A4 (en) * | 2020-08-06 | 2024-03-20 | Affera Inc | Systems for tissue stimulation and associated methods |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5224476A (en) * | 1992-02-24 | 1993-07-06 | Duke University | Method and apparatus for controlling fibrillation or tachycardia |
| US5376105A (en) * | 1992-06-17 | 1994-12-27 | Siemens Aktiengesellschaft | Defibrillator/cardioverter |
| US5584865A (en) * | 1993-09-24 | 1996-12-17 | Pacesetter Ab | Defibrillator with output stage using switching network and three electrode |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR219066A1 (en) * | 1977-02-14 | 1980-07-31 | Trabucco H | IMPROVEMENTS IN A CATETER ELECTRODE |
| US4030509A (en) * | 1975-09-30 | 1977-06-21 | Mieczyslaw Mirowski | Implantable electrodes for accomplishing ventricular defibrillation and pacing and method of electrode implantation and utilization |
| FR2510390B1 (en) * | 1981-07-31 | 1986-06-06 | Cardiofrance Co | SLIDING COAXIAL PROBE FOR HEART STIMULATOR |
| US4708145A (en) * | 1982-06-01 | 1987-11-24 | Medtronic, Inc. | Sequential-pulse, multiple pathway defibrillation method |
| US4628937A (en) * | 1984-08-02 | 1986-12-16 | Cordis Corporation | Mapping electrode assembly |
| US4641656A (en) * | 1985-06-20 | 1987-02-10 | Medtronic, Inc. | Cardioversion and defibrillation lead method |
| SE8800019D0 (en) * | 1988-01-07 | 1988-01-07 | Knut Olof Edhag | FOR CARDIALLY DEFIBLATION USED INTRAVASCULES ELECTRO CABLE |
| US5411527A (en) * | 1989-05-03 | 1995-05-02 | Intermedics, Inc. | Difibrillation electrodes and implantation |
| US4969463A (en) * | 1989-06-06 | 1990-11-13 | Cardiac Pacemakers, Inc. | Defibrillation electrode and method for employing gatling discharge defibrillation |
| US5103822A (en) * | 1990-04-03 | 1992-04-14 | Siemens-Pacesetter, Inc. | Pacing system for termination of cardiac arrhythmias utilizing scanning techniques |
| US5050601A (en) * | 1990-05-29 | 1991-09-24 | Joel Kupersmith | Cardiac defibrillator electrode arrangement |
| US5203348A (en) * | 1990-06-06 | 1993-04-20 | Cardiac Pacemakers, Inc. | Subcutaneous defibrillation electrodes |
| US5230337A (en) * | 1990-06-06 | 1993-07-27 | Cardiac Pacemakers, Inc. | Process for implanting subcutaneous defibrillation electrodes |
| US5282845A (en) * | 1990-10-01 | 1994-02-01 | Ventritex, Inc. | Multiple electrode deployable lead |
| US5425364A (en) * | 1991-02-15 | 1995-06-20 | Cardiac Pathways Corporation | Flexible strip assembly without feedthrough holes and device utilizing the same |
| US5456254A (en) * | 1991-02-15 | 1995-10-10 | Cardiac Pathways Corp | Flexible strip assembly having insulating layer with conductive pads exposed through insulating layer and device utilizing the same |
| US5433729A (en) * | 1991-04-12 | 1995-07-18 | Incontrol, Inc. | Atrial defibrillator, lead systems, and method |
| US5327909A (en) * | 1991-04-26 | 1994-07-12 | Angeion Corporation | Epicardial defibrillator lead |
| US5181511A (en) * | 1991-10-21 | 1993-01-26 | Telectronics Pacing Systems, Inc. | Apparatus and method for antitachycardia pacing using a virtual electrode |
| SE9203734D0 (en) * | 1992-12-11 | 1992-12-11 | Siemens Elema Ab | defibrillation |
| US5468254A (en) * | 1993-07-26 | 1995-11-21 | Cardiac Pacemakers, Inc. | Method and apparatus for defibrillation using a multiphasic truncated exponential waveform |
| US5405374A (en) * | 1993-08-25 | 1995-04-11 | Medtronic, Inc. | Transvenous defibrillation lead and method of use |
| US5489293A (en) * | 1993-08-31 | 1996-02-06 | Ventritex, Inc. | Method and apparatus for treating cardiac tachyarrhythmia |
| US5439485A (en) * | 1993-09-24 | 1995-08-08 | Ventritex, Inc. | Flexible defibrillation electrode of improved construction |
| US5514164A (en) * | 1994-03-25 | 1996-05-07 | Pacesetter, Inc. | DDD pacing response to atrial tachyucardia and retrograde conduction |
-
1997
- 1997-10-29 US US08/960,448 patent/US5995871A/en not_active Expired - Fee Related
-
1998
- 1998-10-26 WO PCT/US1998/022660 patent/WO1999021611A1/en active Application Filing
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5224476A (en) * | 1992-02-24 | 1993-07-06 | Duke University | Method and apparatus for controlling fibrillation or tachycardia |
| US5376105A (en) * | 1992-06-17 | 1994-12-27 | Siemens Aktiengesellschaft | Defibrillator/cardioverter |
| US5584865A (en) * | 1993-09-24 | 1996-12-17 | Pacesetter Ab | Defibrillator with output stage using switching network and three electrode |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001021254A1 (en) * | 1999-09-23 | 2001-03-29 | Ben-Gurion University Of The Negev Research & Development Authority | Method and device for the cancellation of unwanted excitation waves in the heart |
| EP1696999A2 (en) * | 2003-07-21 | 2006-09-06 | Ai-Semi Ltd. | Adaptive resynchronization therapy system |
| EP1696999A4 (en) * | 2003-07-21 | 2008-05-28 | Ai Semi Ltd | Adaptive resynchronization therapy system |
Also Published As
| Publication number | Publication date |
|---|---|
| US5995871A (en) | 1999-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5995871A (en) | System and method for cardioversion using scan stimulation | |
| EP1057497B1 (en) | Cardioversion arrangement | |
| EP0060117B1 (en) | Synchronized intracardiac cardioverter | |
| CA2359290C (en) | Antitachycardial pacing | |
| US5632267A (en) | Heart defibrillator and defibrillation method wherein defibrillation is achieved by high-frequency, low-energy pulses | |
| US6470211B1 (en) | Method and apparatus for treating cardiac arrhythmia | |
| US5489293A (en) | Method and apparatus for treating cardiac tachyarrhythmia | |
| EP0220916B1 (en) | Apparatus for recognition of ventricular tachycardia and ventricular fibrillation and for termination thereof | |
| JP4163855B2 (en) | System to remove atrial fibrillation by double shock | |
| EP0928214B1 (en) | Dual current pathway atrial defibrillation apparatus | |
| US20050075677A1 (en) | Multiple pacing output channels | |
| US6668193B2 (en) | Method and apparatus for cardiac shock therapy | |
| WO1995028987A1 (en) | Method and apparatus for treatment of atrial fibrillation | |
| JPH05137801A (en) | Implantable electric-defibrillator for atrium and electric defibrillation /defibrillator, and implantable electric-defibrillator for atrial tachycardia and operating method terefor | |
| CA2196432A1 (en) | Atrial defibrillator and method of use | |
| US7917216B1 (en) | Multi-site pacing for atrial tachyarrhythmias | |
| US7212857B2 (en) | Implantable cardiac device for restoring inter-chamber synchrony and method | |
| US20050049516A1 (en) | Methods, systems and computer program products for selectively initiating interventional therapy to reduce the risk of arrhythmia | |
| US6456876B1 (en) | Dual-chamber implantable cardiac stimulation system and device with selectable arrhythmia termination electrode configurations and method | |
| JPH09103504A (en) | Implantable cardiac defibrillator | |
| US6256535B1 (en) | Method for delivering cardiac therapy and a cardiac therapy device for implementing the same | |
| US6987999B1 (en) | Implantable defibrillator with alternating counter electrode | |
| US20050075674A1 (en) | Extra-systolic stimulation therapy delivery and sensing via different electrode sets | |
| Davies | Control of pathological tachycardias by implantable pulse generators |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA JP |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: CA |